An illustration of a hepatitis C virus
We have a page for each of the #LONGEVITYproject diseases that explains:
❓Why we're focusing on that disease
🧪What we're working on
📌Where we're up to
Our page for hepatitis C virus includes a map of the project's milestones:
www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social
🧵2/2
The #LONGEVITYproject is a consortium, funded by global health agency @unitaid.bsky.social, working to bring long-acting tuberculosis and malaria preventative and a one-shot-cure for hepatitis C virus to patients in low- and middle- income countries.
A woman looks over the land at the sunrise. Text reads "Subscribe to our mailing list"
🧵1/2
We send a quarterly #LONGEVITYproject newsletter in case you missed any of our news from the last few months.
We use it to update you on news, LONGEVITY relevant events and any upcoming opportunities.
If you aren't subscribed, you can sign up here: www.liverpool.ac.uk/celt-global-...
Professor Steve Rannard receiving the Runner Up SCI Forum Award
📣We received the @sciupdate.bsky.social Formulation Forum Innovation Runner Up Award!
It recognises our work on a long-acting one-shot-cure for patients with hepatitis C virus in low- and middle- income countries
Read more: www.liverpool.ac.uk/celt-global-...
#LONGEVITYproject @unitaid.bsky.social
Dr Marcia Vermeulen is behind a lectern presenting a talk at the University of Cape Town. The blog title is written over the top "From vision to impact: Redefining STEM by closing the gender gap with Dr Marcia Vermeulen".
In this piece, Dr Marcia Vermeulen tells us about her research journey including work with the #LONGEVITYproject on our tuberculosis community engagement work.
As it was International Women's Day yesterday we're sharing it again for you.
www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social
A solar system made up of "materials chemistry + pharmacology + regulatory expertise + community engagement = new long-acting medicines"
#LONGEVITYproject is a consortium researching long-acting malaria and TB preventatives, and a one-shot cure for patients with hepatitis C virus.
We explain more about LONGEVITY on our website, including pages about the work for each disease:
www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social
A woman looks over the land at the sunrise. Text reads "Subscribe to our mailing list"
Are you signed up the #LONGEVITYproject newsletter?
Every quarter we send an email updating you with news from the last few months, and let you know about upcoming LONGEVITY relevant events and opportunities.
You can subscribe via the link: www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social
Dr Marcia Vermeulen is behind a lectern presenting a talk at the University of Cape Town. The blog title is written over the top "From vision to impact: Redefining STEM by closing the gender gap with Dr Marcia Vermeulen".
For @unesco.org's International Day of Women and Girls in Science, we spoke to Dr Marcia Vermeulen from University of Cape Town, who oversaw #LONGEVITYproject tuberculosis community engagement work with patients and providers: www.liverpool.ac.uk/celt-global-...
#February11
@unitaid.bsky.social
a blurred image to tease a LONGEVITY map
🧵1/4
We're trying to make sure our work on the #LONGEVITYproject is as transparent as possible.
Funded by @unitaid.bsky.social, we've created a breakdown of what the work for each disease looks like.
We hope an accessible explanation will help show the journey of each disease.
A solar system made up of "materials chemistry + pharmacology + regulatory expertise + community engagement = new long-acting medicines"
Are you subscribed to our #LONGEVITYproject newsletter?
A quarterly update of the international consortium work (funded by @unitaid.bsky.social) to bring long-acting treatments or preventatives to patients with tuberculosis, hepatitis C virus and malaria in LMICs
www.liverpool.ac.uk/celt-global-...
CELT Global Health scientists are working in the lab. The blog title is written over the top: "2025 wrap up: The LONGEVITY project"
We've compiled what 2025 looked like for the #LONGEVITYproject.
The achievements and news get us closer to our goal to bring long-acting preventatives/treatments for malaria, TB and hepatitis C to patients in LMICs where the need is greatest.
www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social
A woman looks over the land at the sunrise. Text reads "Subscribe to our mailing list"
Are you signed up to the quarterly #LONGEVITYproject newsletter?
The international consortium aim to bring long-acting preventatives/treatments to HCV, malaria and TB patients in LMICs, where these diseases have the biggest impact.
Sign up: www.liverpool.ac.uk/centre-of-ex...
@unitaid.bsky.social
An illustration of a hepatitis C virus with the title "Hepatitis Testing Day 2025: Not just a US issue"
17-23 November is @worldhepalliance.bsky.social #WorldHepatitisTestingWeek.
We wrote a blog on hepatitis testing as a global issue
The #LONGEVITYproject, is working on a one-shot-cure for HCV to provide patients in LMICs treatment at diagnosis
www.liverpool.ac.uk/centre-of-ex...
@unitaid.bsky.social
An illustration of a globe with items leading away from it, they read "materials chemistry + pharmacology + regulatory expertise + community engagement = new long-acting medicines"
Are you subscribed to our quarterly #LONGEVITYproject newsletter?
We update LONGEVITY news, opportunities and global events.
LONGEVITY, funded by @unitaid.bsky.social, is working to create long-acting malaria, TB and HCV medicines for patients in LMICs.
Sign up: www.liverpool.ac.uk/centre-of-ex...
A woman looks into the sunrise over a beautiful landscape. The text reads "LONGEVITY Project: Aiming to reduce the burden of disease in low- and middle- income countries"
Next week is our quarterly #LONGEVITYproject newsletter.
This quarter includes:
- Work from partners @treatmentactiongroup.org and CHAI.
- Recent hepatitis C virus proof of concept news
- Community of Practice meeting highlights.
Subscribe: www.liverpool.ac.uk/centre-of-ex...
@unitaid.bsky.social
The words "LONGEVITY Project" are surrounded by illustrations of tuberculosis bacteria, a hepatitis C virus and a malaria infected red blood cell. The University of Liverpool, LONGEVITY logo and Unitaid logos are in the corners along with the LONGEVITY web address "www.liverpool.ac.uk/longevity"
17 September is #InternationalMicroorganismDay and @who.int's #PatientSafetyDay
We're highlighting #LONGEVITYproject. Explore the impact of the project diseases (HCV, malaria and TB) and our long-acting options work to keep LMIC patients safe from them.
www.liverpool.ac.uk/centre-of-ex...
We look over a woman's shoulder as she gazes over the landscape at sunrise. The Longevity logo is at the top and text reads "Subscribe to our mailing list".
Are you subscribed to our quarterly #LONGEVITYproject newsletter?
We use it to share news, events and opportunities within our international consortium in our work towards creating long-acting therapeutics for HCV, malaria and TB in LMICs.
Subscribe here: www.liverpool.ac.uk/centre-of-ex...
We're looking forward to this next month.
CELT are presenting and some #LONGEVITYproject work, funded by @unitaid.bsky.social, is being represented as well.
If you're there, please find us to say hi.
An illustration of magnified tuberculosis bacteria
CELT's #LONGEVITYproject research, funded by @unitaid.bsky.social, includes long-acting tuberculosis preventative therapies for patients in low- and middle- income countries, to help people avoid contracting TB disease.
Find out more about LONGEVITY's TB work: www.liverpool.ac.uk/centre-of-ex...
We look over a woman's shoulder as she gazes over the landscape at sunrise. The Longevity logo is at the top and text reads "Subscribe to our mailing list".
We send quarterly newsletters for the #LONGEVITYproject, funded by @unitaid.bsky.social.
The newsletter lets you know the news from our international consortium, any LONGEVITY related opportunities and upcoming events where our work will be presented.
Subscribe: www.liverpool.ac.uk/centre-of-ex...
#LONGEVITYproject partner @treatmentactiongroup.org illustrated a #WorldHepatitisDay storyboard
It's Sibusiso Dlamini's HCV experience, which is the story of how important accessible care is for HCV diagnosis, treatment and aftercare
www.treatmentactiongroup.org/publication/...
@unitaid.bsky.social
Dr Usman Arshad is smiling into the camera standing in front of the poster being presented at CROI 2025. The blog title is written over the top;"Let's break it down: Exciting long-acting hepatitis C virus update for World Hepatitis Day 2025"
28 July is #WorldHepatitisDay.
#LONGEVITYproject, funded by @unitaid.bsky.social, spent time at CROI showing proof-of-concept of a solid long-acting injectable hepatitis C virus treatment with @jhu.edu that could offer a one-shot-cure option for HCV.
Read more: www.liverpool.ac.uk/centre-of-ex...
5 CELT staff and 2 Unitaid visitors are stood on a light and open walkway all smiling at the camera.
Two weeks ago @unitaid.bsky.social visited CELT at @liverpooluni.bsky.social.
We delved into plans for our #LONGEVITYproject and additional Unitaid funded 2027 goals.
We meet online regularly, but in person felt really collaborative.
Find out about LONGEVITY: www.liverpool.ac.uk/centre-of-ex...
Panel members from the webinar are smiling. The blog title is written over the top "LONGEVITY Community Engagement: Perspectives of people with HCV and TB lived experience, and healthcare providers on potential long-acting therapies"
In May, the @treatmentactiongroup.org(TAG) held a 90 minute webinar presenting all the current community and civil society engagement work from the #LONGEVITYproject.
Read all about it and find links to slides and a recording via the link: www.liverpool.ac.uk/centre-of-ex...
A woman is holding her hand up against the light of the rising sun. The text reads "subscribe to our mailing list"
Next week is our quarterly #LONGEVITYproject newsletter.
It includes exciting news about LONGEVITY work from @unmc.bsky.social, @treatmentactiongroup.org and @cidri-africa.bsky.social, and more.
Subscribe to the LONGEVITY mailing list: www.liverpool.ac.uk/centre-of-ex...
@unitaid.bsky.social
Read a recent report from @treatmentactiongroup.org, bringing together #LONGEVITYproject low- and middle- income countries' (LMICs) hepatitis C virus community and civil society engagement research, funded by global health agency @unitaid.bsky.social.
www.treatmentactiongroup.org/publication/...
#LONGEVITYproject, funded by global health agency @unitaid.bsky.social, is an ambitious one that hopes to be part of eradicating devastating diseases in low- and middle- income countries. Patient and provider involvement in our work makes sure what we hope a solution is and what patients want align.
Hosted by @treatmentactiongroup.org and Afrocab, partners of the #LONGEVITYproject will present findings from LONGEVITY's diverse LMICs' patients and providers community engagement work.
⏰Friday 30 May, 8.30-10am EDT (1.30-3pm BST). Links to register in the post below.
@unitaid.bsky.social
An illustration of a hepatitis C virus with the blog title written over the top: "Hepatitis Testing Day 2025: Not just a US issue"
19 April is #NationalHepatitisTestingDay.
#LONGEVITYproject, funded by @unitaid.bsky.social, is working to create long-acting versions of existing #HCV medicines for patients in LMICs.
Knowing our hepatitis status is a key global message.
Read more:
www.liverpool.ac.uk/centre-of-ex...
#HepAware
Dr Vermeulen is wearing a stripey cardigan and smiling into the camera in front of the poster in the CROI 2025 poster presentation hall
The International Journal of Tuberculosis and Lung Disease has published #LONGEVITYproject research
@unmc.bsky.social, @treatmentactiongroup.org & @cidri-africa.bsky.social surveyed 400 patients, 75% wanted to try long-acting TB therapeutics
www.liverpool.ac.uk/centre-of-ex...
@unitaid.bsky.social
